TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study

SIMPLE SUMMARY: The status of microsatellite instability (MSI-H) in gastric or gastroesophageal junction cancer (GC/GEJC) patients eligible for radical surgery proved to be prognostic for an improved survival outcome and predictive for poor/no benefit from the combination of adjuvant/peri-operative...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Raimondi, Alessandra, Palermo, Federica, Prisciandaro, Michele, Aglietta, Massimo, Antonuzzo, Lorenzo, Aprile, Giuseppe, Berardi, Rossana, Cardellino, Giovanni G., De Manzoni, Giovanni, De Vita, Ferdinando, Di Maio, Massimo, Fornaro, Lorenzo, Frassineti, Giovanni L., Granetto, Cristina, Iachetta, Francesco, Lonardi, Sara, Murialdo, Roberto, Ongaro, Elena, Pucci, Francesca, Ratti, Margherita, Silvestris, Nicola, Smiroldo, Valeria, Spallanzani, Andrea, Strippoli, Antonia, Tamberi, Stefano, Tamburini, Emiliano, Zaniboni, Alberto, Di Bartolomeo, Maria, Cremolini, Chiara, Sposito, Carlo, Mazzaferro, Vincenzo, Pietrantonio, Filippo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Study Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8201030/
https://ncbi.nlm.nih.gov/pubmed/34200267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112839
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller